Shire Says Patent Settlements Didn't Delay Generic Adderall

Shire LLC on Friday urged a California federal court to throw out putative class allegations that the drug company stifled competition for Adderall XR through patent settlements and supply agreements with...

Already a subscriber? Click here to view full article